Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
levetiracetam (keppra) (1 trial)
Dyskinesias (Phase 2)
Parkinson Disease (Phase 2)
Trials (1 total)
Trial APIs (1 total)